Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD 42.16
+0.56 (1.35%)
Sep 3, 2025, 4:08 PM HKT
Guangzhou Innogen Pharmaceutical Group Company Description
Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in development of drugs.
Its products are used for treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases.
The company was incorporated in 2014 and is based in Shanghai, China. Guangzhou Innogen Group Co., Ltd. operates as a subsidiary of KPC Pharmaceuticals, Inc.
Guangzhou Innogen Pharmaceutical Group Co., Ltd
| Country | China |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Qinghua Wang |
Contact Details
Address: 720 Cai Lun Road Shanghai China | |
| Website | innogenpharm.com |
Stock Details
| Ticker Symbol | 2591 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000071Q7 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Qinghua Wang | Chief Executive Officer |
| Fan Jiang | Chief Financial Officer |